Jiangsu Nanfang Medical Co., Ltd. (603880.SS)
CNY 4.98
(-0.2%)
CNY 4.98
(-0.2%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -146.82 Million CNY | -36970.43% |
| 2022 | -396.06 Thousand CNY | -105.95% |
| 2021 | 6.66 Million CNY | -95.93% |
| 2020 | 163.77 Million CNY | 264.31% |
| 2019 | 44.95 Million CNY | -0.81% |
| 2018 | 45.32 Million CNY | -8.83% |
| 2017 | 49.71 Million CNY | -18.03% |
| 2016 | 60.64 Million CNY | 1.05% |
| 2015 | 60.01 Million CNY | -0.68% |
| 2014 | 60.43 Million CNY | 8.14% |
| 2013 | 55.87 Million CNY | 19.57% |
| 2012 | 46.73 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -14.66 Million CNY | -573.57% |
| 2024 Q1 | -172.8 Thousand CNY | 99.89% |
| 2024 Q2 | 3.09 Million CNY | 1892.38% |
| 2023 Q2 | 853.51 Thousand CNY | -89.22% |
| 2023 Q1 | 7.91 Million CNY | 121.52% |
| 2023 FY | -146.82 Million CNY | -36970.43% |
| 2023 Q4 | -154.36 Million CNY | -12471.93% |
| 2023 Q3 | -1.22 Million CNY | -243.86% |
| 2022 Q3 | -4.97 Million CNY | -418.93% |
| 2022 Q2 | 1.55 Million CNY | -79.04% |
| 2022 Q1 | 7.43 Million CNY | 115.73% |
| 2022 FY | -396.06 Thousand CNY | -105.95% |
| 2022 Q4 | -36.8 Million CNY | -640.14% |
| 2021 Q4 | -47.28 Million CNY | -958.05% |
| 2021 Q3 | 5.51 Million CNY | 14.01% |
| 2021 Q1 | 8.86 Million CNY | 1262.24% |
| 2021 FY | 6.66 Million CNY | -95.93% |
| 2021 Q2 | 4.83 Million CNY | -45.48% |
| 2020 FY | 163.77 Million CNY | 264.31% |
| 2020 Q4 | -762.86 Thousand CNY | -109.54% |
| 2020 Q1 | 10.42 Million CNY | 192.03% |
| 2020 Q2 | 84.02 Million CNY | 706.29% |
| 2020 Q3 | 7.99 Million CNY | -90.48% |
| 2019 Q3 | 10.57 Million CNY | -31.43% |
| 2019 FY | 44.95 Million CNY | -0.81% |
| 2019 Q4 | -11.32 Million CNY | -207.09% |
| 2019 Q1 | 10.73 Million CNY | 177.98% |
| 2019 Q2 | 15.42 Million CNY | 43.72% |
| 2018 Q3 | 14.58 Million CNY | -52.65% |
| 2018 FY | 45.32 Million CNY | -8.83% |
| 2018 Q4 | -13.75 Million CNY | -194.33% |
| 2018 Q2 | 30.8 Million CNY | 125.02% |
| 2018 Q1 | 13.69 Million CNY | 206.23% |
| 2017 FY | 49.71 Million CNY | -18.03% |
| 2017 Q1 | 12.68 Million CNY | -21.93% |
| 2017 Q2 | 19.39 Million CNY | 52.86% |
| 2017 Q3 | 13.16 Million CNY | -32.13% |
| 2017 Q4 | 4.47 Million CNY | -66.04% |
| 2016 FY | 60.64 Million CNY | 1.05% |
| 2016 Q4 | 16.24 Million CNY | 30.07% |
| 2016 Q3 | 12.49 Million CNY | -21.68% |
| 2016 Q2 | 15.95 Million CNY | 0.0% |
| 2016 Q1 | 15.95 Million CNY | 0.0% |
| 2015 FY | 60.01 Million CNY | -0.68% |
| 2014 FY | 60.43 Million CNY | 8.14% |
| 2013 FY | 55.87 Million CNY | 19.57% |
| 2012 FY | 46.73 Million CNY | 0.0% |